El utilitarismo ha muerto
El GLOBAL
En la filosofía política y jurídica, los utilitaristas se caracterizan por defender que la actuación correcta es la que causa un mayor beneficio o placer a un mayor número de personas. Las instituciones, para los utilitaristas, actúan de forma irreprochable si gestionan los recursos en beneficio del mayor número de personas. Conceptos como la sostenibilidad... Read More
¿Agrupación de biológicos en un mismo lote?
EL GLOBAL
En los procedimientos de contratación pública que tienen por objeto la adquisición de medicamentos biológicos se produce con demasiada frecuencia el problema de cómo el órgano de contratación configura los lotes de la licitación. Motivada posiblemente por un excesivo celo en la contención y control del gasto, la administración tiende a agrupar en un mismo... Read More
Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product
Cuadernos de Derecho Farmacéutico número 52, Enero-Marzo 2015
Summary: In Spain and in other EU Member States, holders of marketing authorizations for reference medicinal products face obstacles when trying to bring national authorities to court in connection with the grant of generic approvals. In many cases, Spanish Courts have denied locus standi claiming that the interest that the claimant is not sufficient to... Read More
Aspects to be considered in the future regulation on public financing and prices of medicinal products
Judgment of the European Court of Justice, of 26 February 2015, and Report of 28 April 2015, of NCMC, on the Draft of the Revised Text of the Law on Guarantees
CAPSULAS Nº 160
Drafting the new Royal Decree on financing and price of medicinal products is, without question, a complex process. The two documents to which we refer in this article bring valuable ideas that should be considered in future regulations. Transparency It is particularly convenient to talk about transparency. The Spanish National Commission for Markets and Competition... Read More
Unilateral and unjustified termination of a license and supply agreement for medicinal products
Judgement of the Provincial Court of Madrid, of 17 December 2014, No 438/2014
Capsulas Nº 160
Background In 2008 two pharmaceutical companies signed a license and supply agreementfor medicinal products, according to which the licensee assumed the obligation to purchase the product exclusively from the licensor for a period of 5 years. Furthermore, a penalty clause was included, according to which in case the licensee purchased the medicinal product from other... Read More
The gifts handed out in a pharmacy do not escape from attention of the health authorities
Judgment of the Superior Court of Justice of Galicia of 29 January 2015
Capsulas Nº 160
Background In this judgment the Superior Court of Justice of Galicia ruled on the administrative appeal lodged by two pharmacists against the fine of 91.000 Euros that was imposed on them by the Galician Department of Health. The Galician health authorities imposed the abovementioned fine because the pharmacists had handed out gifts to clients who... Read More
The parties must abide by the fiscal terms as specified in the agreements, regardless of who the taxable person is
Judgment of the Supreme Court, First Civil Chamber, of 19 January 2015
Capsulas Nº 160
The Ministry of Defence sold several houses to the military men who occupied them. In the purchase agreements both parties agreed that all applicable taxes resulting from the change of ownership of the houses, would be borne by the buyers. The deeds specified that the sale was exempted from the value added tax (VAT) and, therefore,... Read More
Chambers & Partners Guide 2015
The 2015 Edition of the Guide confirms again Faus & Moliner as leader in pharmaceutical law in Spain
For some years now, the Chambers & Partners Guide assesses the reputation and competence of thousands of lawyers in Europe on the basis of interviews that their investigation team carries out directly with clients and other lawyers. This year’s Guide highlights the fact that Faus & Moliner’s has advised Uriach on the sale of its... Read More
Más jurisprudencia europea sobre transparencia
El GLOBAL
Asumiendo que seguimos inmersos en la redacción del nuevo real decreto sobre financiación y precio de los medicamentos, la lectura de la sentencia del Tribunal de Justicia de la Unión Europea de 26 de febrero en el asunto Servier es muy pertinente y recomendable. Los hechos debatidos y la decisión del Tribunal son conocidos. Cuando... Read More
Faus & Moliner participates in the “Master in Pharma and Biotech Business” of Fundación ESAME
Jordi Faus teaches a class on co-marketing and co-promotion agreements
The Master in Pharma and Biotech Business Law, organized by Fundación ESAME, aims to provide specific training applied to the most common agreements in the Pharmaceutical Sector as well as to the regulations of the Pharma & Biotech industry. During his conference held on the 23 of March in Madrid, Jordi Faus focused on the... Read More